Cystic fibrosis and COVID-19: Care considerations
- PMID: 32953446
- PMCID: PMC7492163
- DOI: 10.1016/j.rmcr.2020.101226
Cystic fibrosis and COVID-19: Care considerations
Abstract
The coronavirus disease 2019 (COVID-19) pandemic has demanded large scale changes in patient care. People with cystic fibrosis have unique considerations, including underlying lung disease and routine aerosolizing therapies, but there is insufficient evidence to create comprehensive practice guidelines. We share a case of a patient with CF and COVID-19 as well as alterations to routine CF care at a large academic center. Key considerations include accessible COVID-19 screening, augmented infection control practices, and rapid integration of telemedicine.
Keywords: Covid-19; Cystic fibrosis; Infection control; Pulmonary.
© 2020 The Authors.
Conflict of interest statement
No conflicts of interest to disclose.
Figures
References
-
- Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention. J. Am. Med. Assoc. 2020;323(13):1239–1242. - PubMed
Publication types
LinkOut - more resources
Full Text Sources